Newer vascular targets: Endosialin (Review)

  • Authors:
    • Beverly A. Teicher
  • View Affiliations

  • Published online on: February 1, 2007     https://doi.org/10.3892/ijo.30.2.305
  • Pages: 305-312
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The identification of cell surface markers expressed selectively by tumor vasculature is challenging. To get as close to the human disease as possible, investigators have isolated endothelial cells from fresh human tumor specimens and subjected them to RNA-based gene expression analysis. The data indicate that there are few proteins that distinguish tumor vasculature from normal vasculature and re-enforce the notion that the endothelium is a tissue specialized cell-type. Endosialin was identified as a cell surface tumor endothelial marker. The selective expression of endosialin by tumor vasculature and stroma has been confirmed. Although the function of endosialin remains to be elucidated, the expression pattern for this protein may be favorable for cancer therapy.

Related Articles

Journal Cover

February 2007
Volume 30 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Teicher BA: Newer vascular targets: Endosialin (Review). Int J Oncol 30: 305-312, 2007
APA
Teicher, B.A. (2007). Newer vascular targets: Endosialin (Review). International Journal of Oncology, 30, 305-312. https://doi.org/10.3892/ijo.30.2.305
MLA
Teicher, B. A."Newer vascular targets: Endosialin (Review)". International Journal of Oncology 30.2 (2007): 305-312.
Chicago
Teicher, B. A."Newer vascular targets: Endosialin (Review)". International Journal of Oncology 30, no. 2 (2007): 305-312. https://doi.org/10.3892/ijo.30.2.305